nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefdinir—MPO—Carboplatin—ovarian cancer	0.583	1	CbGbCtD
Cefdinir—SLC15A1—epithelium—ovarian cancer	0.00246	0.0863	CbGeAlD
Cefdinir—MPO—epithelium—ovarian cancer	0.00222	0.0777	CbGeAlD
Cefdinir—SLC15A1—endometrium—ovarian cancer	0.00221	0.0774	CbGeAlD
Cefdinir—SLC22A5—myometrium—ovarian cancer	0.00171	0.0598	CbGeAlD
Cefdinir—SLC15A1—vagina—ovarian cancer	0.00166	0.058	CbGeAlD
Cefdinir—MPO—bone marrow—ovarian cancer	0.00156	0.0545	CbGeAlD
Cefdinir—SLC15A2—uterine cervix—ovarian cancer	0.00153	0.0535	CbGeAlD
Cefdinir—SLC15A2—endometrium—ovarian cancer	0.00138	0.0484	CbGeAlD
Cefdinir—MPO—testis—ovarian cancer	0.00133	0.0466	CbGeAlD
Cefdinir—SLC22A5—uterine cervix—ovarian cancer	0.00133	0.0465	CbGeAlD
Cefdinir—SLC22A5—endometrium—ovarian cancer	0.0012	0.0421	CbGeAlD
Cefdinir—SLC15A2—female reproductive system—ovarian cancer	0.00114	0.0401	CbGeAlD
Cefdinir—SLC15A2—female gonad—ovarian cancer	0.00104	0.0365	CbGeAlD
Cefdinir—SLC15A2—vagina—ovarian cancer	0.00104	0.0363	CbGeAlD
Cefdinir—SLC22A5—female reproductive system—ovarian cancer	0.000995	0.0349	CbGeAlD
Cefdinir—MPO—lymph node—ovarian cancer	0.000964	0.0338	CbGeAlD
Cefdinir—SLC15A2—testis—ovarian cancer	0.000924	0.0324	CbGeAlD
Cefdinir—SLC22A5—female gonad—ovarian cancer	0.000906	0.0317	CbGeAlD
Cefdinir—SLC22A5—vagina—ovarian cancer	0.0009	0.0315	CbGeAlD
Cefdinir—Dyspepsia—Topotecan—ovarian cancer	0.000839	0.00216	CcSEcCtD
Cefdinir—Stomatitis—Paclitaxel—ovarian cancer	0.000838	0.00216	CcSEcCtD
Cefdinir—Conjunctivitis—Paclitaxel—ovarian cancer	0.000835	0.00215	CcSEcCtD
Cefdinir—Vaginal infection—Epirubicin—ovarian cancer	0.000829	0.00213	CcSEcCtD
Cefdinir—Decreased appetite—Topotecan—ovarian cancer	0.000828	0.00213	CcSEcCtD
Cefdinir—Aplastic anaemia—Epirubicin—ovarian cancer	0.000825	0.00212	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Topotecan—ovarian cancer	0.000822	0.00212	CcSEcCtD
Cefdinir—Dyspepsia—Melphalan—ovarian cancer	0.000821	0.00211	CcSEcCtD
Cefdinir—Haematuria—Paclitaxel—ovarian cancer	0.000819	0.00211	CcSEcCtD
Cefdinir—Anaphylactic shock—Vinorelbine—ovarian cancer	0.000815	0.0021	CcSEcCtD
Cefdinir—Constipation—Topotecan—ovarian cancer	0.000815	0.0021	CcSEcCtD
Cefdinir—Vaginal inflammation—Doxorubicin—ovarian cancer	0.000813	0.00209	CcSEcCtD
Cefdinir—Decreased appetite—Melphalan—ovarian cancer	0.000811	0.00209	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000805	0.00207	CcSEcCtD
Cefdinir—SLC22A5—testis—ovarian cancer	0.000803	0.0281	CbGeAlD
Cefdinir—Rash maculo-papular—Epirubicin—ovarian cancer	0.000798	0.00205	CcSEcCtD
Cefdinir—Thrombocytopenia—Vinorelbine—ovarian cancer	0.000798	0.00205	CcSEcCtD
Cefdinir—Melaena—Doxorubicin—ovarian cancer	0.000794	0.00204	CcSEcCtD
Cefdinir—Hypersensitivity—Chlorambucil—ovarian cancer	0.000788	0.00203	CcSEcCtD
Cefdinir—Gastrointestinal pain—Topotecan—ovarian cancer	0.000779	0.002	CcSEcCtD
Cefdinir—Anorexia—Vinorelbine—ovarian cancer	0.000777	0.002	CcSEcCtD
Cefdinir—Candida infection—Doxorubicin—ovarian cancer	0.000776	0.002	CcSEcCtD
Cefdinir—Pancytopenia—Docetaxel—ovarian cancer	0.000776	0.002	CcSEcCtD
Cefdinir—Haemoglobin—Paclitaxel—ovarian cancer	0.000775	0.002	CcSEcCtD
Cefdinir—Haemorrhage—Paclitaxel—ovarian cancer	0.000771	0.00199	CcSEcCtD
Cefdinir—Asthenia—Chlorambucil—ovarian cancer	0.000768	0.00198	CcSEcCtD
Cefdinir—Vaginal infection—Doxorubicin—ovarian cancer	0.000767	0.00197	CcSEcCtD
Cefdinir—Neutropenia—Docetaxel—ovarian cancer	0.000764	0.00197	CcSEcCtD
Cefdinir—Aplastic anaemia—Doxorubicin—ovarian cancer	0.000763	0.00196	CcSEcCtD
Cefdinir—Pruritus—Chlorambucil—ovarian cancer	0.000757	0.00195	CcSEcCtD
Cefdinir—Abdominal pain—Topotecan—ovarian cancer	0.000753	0.00194	CcSEcCtD
Cefdinir—Body temperature increased—Topotecan—ovarian cancer	0.000753	0.00194	CcSEcCtD
Cefdinir—Rash maculo-papular—Doxorubicin—ovarian cancer	0.000739	0.0019	CcSEcCtD
Cefdinir—Pneumonia—Docetaxel—ovarian cancer	0.000733	0.00189	CcSEcCtD
Cefdinir—Diarrhoea—Chlorambucil—ovarian cancer	0.000732	0.00188	CcSEcCtD
Cefdinir—Hepatic function abnormal—Epirubicin—ovarian cancer	0.00073	0.00188	CcSEcCtD
Cefdinir—Erythema multiforme—Paclitaxel—ovarian cancer	0.000729	0.00188	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.000722	0.00186	CcSEcCtD
Cefdinir—Acute coronary syndrome—Docetaxel—ovarian cancer	0.000718	0.00185	CcSEcCtD
Cefdinir—Renal failure—Docetaxel—ovarian cancer	0.000716	0.00184	CcSEcCtD
Cefdinir—Myocardial infarction—Docetaxel—ovarian cancer	0.000714	0.00184	CcSEcCtD
Cefdinir—Jaundice—Docetaxel—ovarian cancer	0.00071	0.00183	CcSEcCtD
Cefdinir—Stomatitis—Docetaxel—ovarian cancer	0.00071	0.00183	CcSEcCtD
Cefdinir—Hepatic failure—Epirubicin—ovarian cancer	0.000709	0.00183	CcSEcCtD
Cefdinir—Decreased appetite—Vinorelbine—ovarian cancer	0.000708	0.00182	CcSEcCtD
Cefdinir—Conjunctivitis—Docetaxel—ovarian cancer	0.000708	0.00182	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000704	0.00181	CcSEcCtD
Cefdinir—Hypersensitivity—Topotecan—ovarian cancer	0.000702	0.00181	CcSEcCtD
Cefdinir—Constipation—Vinorelbine—ovarian cancer	0.000697	0.00179	CcSEcCtD
Cefdinir—Renal failure acute—Epirubicin—ovarian cancer	0.000691	0.00178	CcSEcCtD
Cefdinir—Hypersensitivity—Melphalan—ovarian cancer	0.000687	0.00177	CcSEcCtD
Cefdinir—Asthenia—Topotecan—ovarian cancer	0.000683	0.00176	CcSEcCtD
Cefdinir—Vomiting—Chlorambucil—ovarian cancer	0.00068	0.00175	CcSEcCtD
Cefdinir—Agranulocytosis—Docetaxel—ovarian cancer	0.00068	0.00175	CcSEcCtD
Cefdinir—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.000676	0.00174	CcSEcCtD
Cefdinir—Hepatic function abnormal—Doxorubicin—ovarian cancer	0.000675	0.00174	CcSEcCtD
Cefdinir—Pruritus—Topotecan—ovarian cancer	0.000674	0.00173	CcSEcCtD
Cefdinir—Renal impairment—Epirubicin—ovarian cancer	0.00067	0.00172	CcSEcCtD
Cefdinir—SLC15A2—lymph node—ovarian cancer	0.000669	0.0235	CbGeAlD
Cefdinir—Asthenia—Melphalan—ovarian cancer	0.000669	0.00172	CcSEcCtD
Cefdinir—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000666	0.00171	CcSEcCtD
Cefdinir—Flatulence—Paclitaxel—ovarian cancer	0.000662	0.0017	CcSEcCtD
Cefdinir—Purpura—Epirubicin—ovarian cancer	0.000661	0.0017	CcSEcCtD
Cefdinir—Pruritus—Melphalan—ovarian cancer	0.00066	0.0017	CcSEcCtD
Cefdinir—Haemoglobin—Docetaxel—ovarian cancer	0.000657	0.00169	CcSEcCtD
Cefdinir—Hepatic failure—Doxorubicin—ovarian cancer	0.000656	0.00169	CcSEcCtD
Cefdinir—Haemorrhage—Docetaxel—ovarian cancer	0.000654	0.00168	CcSEcCtD
Cefdinir—Cardiac failure—Epirubicin—ovarian cancer	0.000653	0.00168	CcSEcCtD
Cefdinir—Diarrhoea—Topotecan—ovarian cancer	0.000652	0.00168	CcSEcCtD
Cefdinir—Abdominal pain—Vinorelbine—ovarian cancer	0.000644	0.00166	CcSEcCtD
Cefdinir—Body temperature increased—Vinorelbine—ovarian cancer	0.000644	0.00166	CcSEcCtD
Cefdinir—Renal failure acute—Doxorubicin—ovarian cancer	0.000639	0.00164	CcSEcCtD
Cefdinir—Diarrhoea—Melphalan—ovarian cancer	0.000638	0.00164	CcSEcCtD
Cefdinir—Nausea—Chlorambucil—ovarian cancer	0.000636	0.00164	CcSEcCtD
Cefdinir—Dizziness—Topotecan—ovarian cancer	0.00063	0.00162	CcSEcCtD
Cefdinir—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.000625	0.00161	CcSEcCtD
Cefdinir—Renal impairment—Doxorubicin—ovarian cancer	0.00062	0.00159	CcSEcCtD
Cefdinir—Erythema multiforme—Docetaxel—ovarian cancer	0.000618	0.00159	CcSEcCtD
Cefdinir—Agitation—Paclitaxel—ovarian cancer	0.000617	0.00159	CcSEcCtD
Cefdinir—Purpura—Doxorubicin—ovarian cancer	0.000612	0.00157	CcSEcCtD
Cefdinir—Vomiting—Topotecan—ovarian cancer	0.000606	0.00156	CcSEcCtD
Cefdinir—Cardiac failure—Doxorubicin—ovarian cancer	0.000604	0.00156	CcSEcCtD
Cefdinir—Leukopenia—Paclitaxel—ovarian cancer	0.000601	0.00155	CcSEcCtD
Cefdinir—Rash—Topotecan—ovarian cancer	0.000601	0.00155	CcSEcCtD
Cefdinir—Hypersensitivity—Vinorelbine—ovarian cancer	0.0006	0.00154	CcSEcCtD
Cefdinir—Dermatitis—Topotecan—ovarian cancer	0.0006	0.00154	CcSEcCtD
Cefdinir—Headache—Topotecan—ovarian cancer	0.000597	0.00154	CcSEcCtD
Cefdinir—Vomiting—Melphalan—ovarian cancer	0.000593	0.00153	CcSEcCtD
Cefdinir—Loss of consciousness—Paclitaxel—ovarian cancer	0.00059	0.00152	CcSEcCtD
Cefdinir—Rash—Melphalan—ovarian cancer	0.000588	0.00151	CcSEcCtD
Cefdinir—Dermatitis—Melphalan—ovarian cancer	0.000588	0.00151	CcSEcCtD
Cefdinir—Asthenia—Vinorelbine—ovarian cancer	0.000585	0.0015	CcSEcCtD
Cefdinir—SLC22A5—lymph node—ovarian cancer	0.000582	0.0204	CbGeAlD
Cefdinir—Convulsion—Paclitaxel—ovarian cancer	0.000582	0.0015	CcSEcCtD
Cefdinir—Hypertension—Paclitaxel—ovarian cancer	0.00058	0.00149	CcSEcCtD
Cefdinir—Pruritus—Vinorelbine—ovarian cancer	0.000577	0.00148	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.000574	0.00148	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.000574	0.00148	CcSEcCtD
Cefdinir—Chest pain—Paclitaxel—ovarian cancer	0.000572	0.00147	CcSEcCtD
Cefdinir—Nausea—Topotecan—ovarian cancer	0.000566	0.00146	CcSEcCtD
Cefdinir—Dry mouth—Paclitaxel—ovarian cancer	0.000559	0.00144	CcSEcCtD
Cefdinir—Diarrhoea—Vinorelbine—ovarian cancer	0.000558	0.00143	CcSEcCtD
Cefdinir—Nausea—Melphalan—ovarian cancer	0.000554	0.00143	CcSEcCtD
Cefdinir—Asthma—Epirubicin—ovarian cancer	0.000551	0.00142	CcSEcCtD
Cefdinir—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000548	0.00141	CcSEcCtD
Cefdinir—Shock—Paclitaxel—ovarian cancer	0.000539	0.00139	CcSEcCtD
Cefdinir—Dizziness—Vinorelbine—ovarian cancer	0.000539	0.00139	CcSEcCtD
Cefdinir—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000537	0.00138	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000531	0.00137	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000531	0.00137	CcSEcCtD
Cefdinir—Pancytopenia—Epirubicin—ovarian cancer	0.000523	0.00135	CcSEcCtD
Cefdinir—Anorexia—Paclitaxel—ovarian cancer	0.000522	0.00134	CcSEcCtD
Cefdinir—Vomiting—Vinorelbine—ovarian cancer	0.000518	0.00133	CcSEcCtD
Cefdinir—Neutropenia—Epirubicin—ovarian cancer	0.000515	0.00133	CcSEcCtD
Cefdinir—Rash—Vinorelbine—ovarian cancer	0.000514	0.00132	CcSEcCtD
Cefdinir—Dermatitis—Vinorelbine—ovarian cancer	0.000513	0.00132	CcSEcCtD
Cefdinir—Headache—Vinorelbine—ovarian cancer	0.00051	0.00131	CcSEcCtD
Cefdinir—Asthma—Doxorubicin—ovarian cancer	0.00051	0.00131	CcSEcCtD
Cefdinir—Leukopenia—Docetaxel—ovarian cancer	0.00051	0.00131	CcSEcCtD
Cefdinir—Loss of consciousness—Docetaxel—ovarian cancer	0.0005	0.00129	CcSEcCtD
Cefdinir—Insomnia—Paclitaxel—ovarian cancer	0.000496	0.00128	CcSEcCtD
Cefdinir—Pneumonia—Epirubicin—ovarian cancer	0.000494	0.00127	CcSEcCtD
Cefdinir—Convulsion—Docetaxel—ovarian cancer	0.000493	0.00127	CcSEcCtD
Cefdinir—Hypertension—Docetaxel—ovarian cancer	0.000491	0.00126	CcSEcCtD
Cefdinir—Somnolence—Paclitaxel—ovarian cancer	0.000487	0.00125	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000487	0.00125	CcSEcCtD
Cefdinir—Chest pain—Docetaxel—ovarian cancer	0.000485	0.00125	CcSEcCtD
Cefdinir—Pancytopenia—Doxorubicin—ovarian cancer	0.000484	0.00125	CcSEcCtD
Cefdinir—Nausea—Vinorelbine—ovarian cancer	0.000484	0.00125	CcSEcCtD
Cefdinir—Renal failure—Epirubicin—ovarian cancer	0.000483	0.00124	CcSEcCtD
Cefdinir—Dyspepsia—Paclitaxel—ovarian cancer	0.000482	0.00124	CcSEcCtD
Cefdinir—Stomatitis—Epirubicin—ovarian cancer	0.000479	0.00123	CcSEcCtD
Cefdinir—Jaundice—Epirubicin—ovarian cancer	0.000479	0.00123	CcSEcCtD
Cefdinir—Conjunctivitis—Epirubicin—ovarian cancer	0.000478	0.00123	CcSEcCtD
Cefdinir—Neutropenia—Doxorubicin—ovarian cancer	0.000477	0.00123	CcSEcCtD
Cefdinir—Decreased appetite—Paclitaxel—ovarian cancer	0.000476	0.00123	CcSEcCtD
Cefdinir—Dry mouth—Docetaxel—ovarian cancer	0.000474	0.00122	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000473	0.00122	CcSEcCtD
Cefdinir—Constipation—Paclitaxel—ovarian cancer	0.000469	0.00121	CcSEcCtD
Cefdinir—Haematuria—Epirubicin—ovarian cancer	0.000468	0.00121	CcSEcCtD
Cefdinir—Anaphylactic shock—Docetaxel—ovarian cancer	0.000465	0.0012	CcSEcCtD
Cefdinir—Agranulocytosis—Epirubicin—ovarian cancer	0.000458	0.00118	CcSEcCtD
Cefdinir—Pneumonia—Doxorubicin—ovarian cancer	0.000457	0.00118	CcSEcCtD
Cefdinir—Shock—Docetaxel—ovarian cancer	0.000457	0.00118	CcSEcCtD
Cefdinir—Thrombocytopenia—Docetaxel—ovarian cancer	0.000455	0.00117	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000451	0.00116	CcSEcCtD
Cefdinir—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000448	0.00115	CcSEcCtD
Cefdinir—Renal failure—Doxorubicin—ovarian cancer	0.000447	0.00115	CcSEcCtD
Cefdinir—Haemoglobin—Epirubicin—ovarian cancer	0.000443	0.00114	CcSEcCtD
Cefdinir—Stomatitis—Doxorubicin—ovarian cancer	0.000443	0.00114	CcSEcCtD
Cefdinir—Jaundice—Doxorubicin—ovarian cancer	0.000443	0.00114	CcSEcCtD
Cefdinir—Anorexia—Docetaxel—ovarian cancer	0.000443	0.00114	CcSEcCtD
Cefdinir—Conjunctivitis—Doxorubicin—ovarian cancer	0.000442	0.00114	CcSEcCtD
Cefdinir—Haemorrhage—Epirubicin—ovarian cancer	0.000441	0.00113	CcSEcCtD
Cefdinir—Haematuria—Doxorubicin—ovarian cancer	0.000433	0.00112	CcSEcCtD
Cefdinir—Abdominal pain—Paclitaxel—ovarian cancer	0.000433	0.00111	CcSEcCtD
Cefdinir—Body temperature increased—Paclitaxel—ovarian cancer	0.000433	0.00111	CcSEcCtD
Cefdinir—Agranulocytosis—Doxorubicin—ovarian cancer	0.000424	0.00109	CcSEcCtD
Cefdinir—Insomnia—Docetaxel—ovarian cancer	0.00042	0.00108	CcSEcCtD
Cefdinir—Erythema multiforme—Epirubicin—ovarian cancer	0.000417	0.00107	CcSEcCtD
Cefdinir—Somnolence—Docetaxel—ovarian cancer	0.000413	0.00106	CcSEcCtD
Cefdinir—Haemoglobin—Doxorubicin—ovarian cancer	0.00041	0.00106	CcSEcCtD
Cefdinir—Dyspepsia—Docetaxel—ovarian cancer	0.000409	0.00105	CcSEcCtD
Cefdinir—Haemorrhage—Doxorubicin—ovarian cancer	0.000408	0.00105	CcSEcCtD
Cefdinir—Decreased appetite—Docetaxel—ovarian cancer	0.000404	0.00104	CcSEcCtD
Cefdinir—Hypersensitivity—Paclitaxel—ovarian cancer	0.000404	0.00104	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000401	0.00103	CcSEcCtD
Cefdinir—Constipation—Docetaxel—ovarian cancer	0.000397	0.00102	CcSEcCtD
Cefdinir—Asthenia—Paclitaxel—ovarian cancer	0.000393	0.00101	CcSEcCtD
Cefdinir—Pruritus—Paclitaxel—ovarian cancer	0.000388	0.000998	CcSEcCtD
Cefdinir—Erythema multiforme—Doxorubicin—ovarian cancer	0.000386	0.000993	CcSEcCtD
Cefdinir—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00038	0.000977	CcSEcCtD
Cefdinir—Flatulence—Epirubicin—ovarian cancer	0.000378	0.000973	CcSEcCtD
Cefdinir—Diarrhoea—Paclitaxel—ovarian cancer	0.000375	0.000965	CcSEcCtD
Cefdinir—Abdominal pain—Docetaxel—ovarian cancer	0.000367	0.000945	CcSEcCtD
Cefdinir—Body temperature increased—Docetaxel—ovarian cancer	0.000367	0.000945	CcSEcCtD
Cefdinir—Dizziness—Paclitaxel—ovarian cancer	0.000362	0.000933	CcSEcCtD
Cefdinir—Agitation—Epirubicin—ovarian cancer	0.000353	0.000908	CcSEcCtD
Cefdinir—Flatulence—Doxorubicin—ovarian cancer	0.00035	0.000901	CcSEcCtD
Cefdinir—Vomiting—Paclitaxel—ovarian cancer	0.000348	0.000897	CcSEcCtD
Cefdinir—Rash—Paclitaxel—ovarian cancer	0.000346	0.000889	CcSEcCtD
Cefdinir—Dermatitis—Paclitaxel—ovarian cancer	0.000345	0.000888	CcSEcCtD
Cefdinir—Leukopenia—Epirubicin—ovarian cancer	0.000344	0.000884	CcSEcCtD
Cefdinir—Headache—Paclitaxel—ovarian cancer	0.000343	0.000884	CcSEcCtD
Cefdinir—Hypersensitivity—Docetaxel—ovarian cancer	0.000342	0.000881	CcSEcCtD
Cefdinir—Loss of consciousness—Epirubicin—ovarian cancer	0.000337	0.000868	CcSEcCtD
Cefdinir—Asthenia—Docetaxel—ovarian cancer	0.000333	0.000858	CcSEcCtD
Cefdinir—Convulsion—Epirubicin—ovarian cancer	0.000333	0.000856	CcSEcCtD
Cefdinir—Hypertension—Epirubicin—ovarian cancer	0.000331	0.000853	CcSEcCtD
Cefdinir—Pruritus—Docetaxel—ovarian cancer	0.000329	0.000846	CcSEcCtD
Cefdinir—Chest pain—Epirubicin—ovarian cancer	0.000327	0.000841	CcSEcCtD
Cefdinir—Agitation—Doxorubicin—ovarian cancer	0.000326	0.00084	CcSEcCtD
Cefdinir—Nausea—Paclitaxel—ovarian cancer	0.000326	0.000838	CcSEcCtD
Cefdinir—Dry mouth—Epirubicin—ovarian cancer	0.00032	0.000823	CcSEcCtD
Cefdinir—Leukopenia—Doxorubicin—ovarian cancer	0.000318	0.000818	CcSEcCtD
Cefdinir—Diarrhoea—Docetaxel—ovarian cancer	0.000318	0.000818	CcSEcCtD
Cefdinir—Anaphylactic shock—Epirubicin—ovarian cancer	0.000313	0.000806	CcSEcCtD
Cefdinir—Loss of consciousness—Doxorubicin—ovarian cancer	0.000312	0.000803	CcSEcCtD
Cefdinir—Shock—Epirubicin—ovarian cancer	0.000308	0.000793	CcSEcCtD
Cefdinir—Convulsion—Doxorubicin—ovarian cancer	0.000308	0.000792	CcSEcCtD
Cefdinir—Dizziness—Docetaxel—ovarian cancer	0.000307	0.00079	CcSEcCtD
Cefdinir—Thrombocytopenia—Epirubicin—ovarian cancer	0.000307	0.000789	CcSEcCtD
Cefdinir—Hypertension—Doxorubicin—ovarian cancer	0.000307	0.000789	CcSEcCtD
Cefdinir—Chest pain—Doxorubicin—ovarian cancer	0.000302	0.000778	CcSEcCtD
Cefdinir—Anorexia—Epirubicin—ovarian cancer	0.000299	0.000769	CcSEcCtD
Cefdinir—Dry mouth—Doxorubicin—ovarian cancer	0.000296	0.000761	CcSEcCtD
Cefdinir—Vomiting—Docetaxel—ovarian cancer	0.000295	0.00076	CcSEcCtD
Cefdinir—Rash—Docetaxel—ovarian cancer	0.000293	0.000754	CcSEcCtD
Cefdinir—Dermatitis—Docetaxel—ovarian cancer	0.000293	0.000753	CcSEcCtD
Cefdinir—Headache—Docetaxel—ovarian cancer	0.000291	0.000749	CcSEcCtD
Cefdinir—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00029	0.000746	CcSEcCtD
Cefdinir—Shock—Doxorubicin—ovarian cancer	0.000285	0.000734	CcSEcCtD
Cefdinir—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000284	0.00073	CcSEcCtD
Cefdinir—Insomnia—Epirubicin—ovarian cancer	0.000283	0.000729	CcSEcCtD
Cefdinir—Somnolence—Epirubicin—ovarian cancer	0.000279	0.000717	CcSEcCtD
Cefdinir—Anorexia—Doxorubicin—ovarian cancer	0.000276	0.000711	CcSEcCtD
Cefdinir—Nausea—Docetaxel—ovarian cancer	0.000276	0.00071	CcSEcCtD
Cefdinir—Dyspepsia—Epirubicin—ovarian cancer	0.000276	0.00071	CcSEcCtD
Cefdinir—Decreased appetite—Epirubicin—ovarian cancer	0.000272	0.000701	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000271	0.000696	CcSEcCtD
Cefdinir—Constipation—Epirubicin—ovarian cancer	0.000268	0.000689	CcSEcCtD
Cefdinir—Insomnia—Doxorubicin—ovarian cancer	0.000262	0.000675	CcSEcCtD
Cefdinir—Somnolence—Doxorubicin—ovarian cancer	0.000258	0.000663	CcSEcCtD
Cefdinir—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000256	0.000659	CcSEcCtD
Cefdinir—Dyspepsia—Doxorubicin—ovarian cancer	0.000255	0.000657	CcSEcCtD
Cefdinir—Decreased appetite—Doxorubicin—ovarian cancer	0.000252	0.000649	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.00025	0.000644	CcSEcCtD
Cefdinir—Constipation—Doxorubicin—ovarian cancer	0.000248	0.000638	CcSEcCtD
Cefdinir—Abdominal pain—Epirubicin—ovarian cancer	0.000248	0.000637	CcSEcCtD
Cefdinir—Body temperature increased—Epirubicin—ovarian cancer	0.000248	0.000637	CcSEcCtD
Cefdinir—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000237	0.00061	CcSEcCtD
Cefdinir—Hypersensitivity—Epirubicin—ovarian cancer	0.000231	0.000594	CcSEcCtD
Cefdinir—Abdominal pain—Doxorubicin—ovarian cancer	0.000229	0.00059	CcSEcCtD
Cefdinir—Body temperature increased—Doxorubicin—ovarian cancer	0.000229	0.00059	CcSEcCtD
Cefdinir—Asthenia—Epirubicin—ovarian cancer	0.000225	0.000578	CcSEcCtD
Cefdinir—Pruritus—Epirubicin—ovarian cancer	0.000222	0.00057	CcSEcCtD
Cefdinir—Diarrhoea—Epirubicin—ovarian cancer	0.000214	0.000552	CcSEcCtD
Cefdinir—Hypersensitivity—Doxorubicin—ovarian cancer	0.000214	0.00055	CcSEcCtD
Cefdinir—Asthenia—Doxorubicin—ovarian cancer	0.000208	0.000535	CcSEcCtD
Cefdinir—Dizziness—Epirubicin—ovarian cancer	0.000207	0.000533	CcSEcCtD
Cefdinir—Pruritus—Doxorubicin—ovarian cancer	0.000205	0.000528	CcSEcCtD
Cefdinir—Vomiting—Epirubicin—ovarian cancer	0.000199	0.000513	CcSEcCtD
Cefdinir—Diarrhoea—Doxorubicin—ovarian cancer	0.000198	0.00051	CcSEcCtD
Cefdinir—Rash—Epirubicin—ovarian cancer	0.000198	0.000508	CcSEcCtD
Cefdinir—Dermatitis—Epirubicin—ovarian cancer	0.000197	0.000508	CcSEcCtD
Cefdinir—Headache—Epirubicin—ovarian cancer	0.000196	0.000505	CcSEcCtD
Cefdinir—Dizziness—Doxorubicin—ovarian cancer	0.000192	0.000493	CcSEcCtD
Cefdinir—Nausea—Epirubicin—ovarian cancer	0.000186	0.000479	CcSEcCtD
Cefdinir—Vomiting—Doxorubicin—ovarian cancer	0.000184	0.000474	CcSEcCtD
Cefdinir—Rash—Doxorubicin—ovarian cancer	0.000183	0.00047	CcSEcCtD
Cefdinir—Dermatitis—Doxorubicin—ovarian cancer	0.000183	0.00047	CcSEcCtD
Cefdinir—Headache—Doxorubicin—ovarian cancer	0.000182	0.000467	CcSEcCtD
Cefdinir—Nausea—Doxorubicin—ovarian cancer	0.000172	0.000443	CcSEcCtD
